COMMETS- Combination MCI Metabolic Syndrome
COMMETS- Combination MCI Metabolic Syndrome
Recruiting · NCT06072963 · Registry updated 2026-07-27Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| COMMETS- Combination MCI Metabolic Syndrome | Alzheimer disease, Cognition Disorders, Cognitive Dysfunction, Insulin Resistance, Mild Cognitive Impairment, Nutritional and Metabolic Diseases, brain disorder, central nervous system disorder, cognitive disorder, dementia, glucose metabolism disease, hyperinsulinism, metabolic disease, nervous system disorder, neurodegenerative disease, psychiatric disorder, tauopathy | Recruiting | Phase 2 | 2026-07-27 | NCT06072963 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Alzheimer's Association | 36 |
| Rutgers, The State University of New Jersey | 154 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Joseph Sagol Neuroscience center, Sheba Medical Center | Ramat Gan | Israel | 1 |